Cargando…

c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1

The crosstalk between osteosarcoma (OS) development and abnormally expressed microRNA (miR)-601 is not explored explicitly. Here, we identified the downregulated miR-601 in osteosarcoma (OS) through a comprehensive bioinformatics analysis of GEO Datasets. The results indicated that miR-601 was downr...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Peng, Fang, Jiarui, Chen, Houqing, He, Feng, Xiao, Siying, Liu, He, Zhu, Shizhuang, Luo, Jianzhou, Jiang, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035158/
https://www.ncbi.nlm.nih.gov/pubmed/35461324
http://dx.doi.org/10.1038/s41598-022-10684-0
_version_ 1784693236945649664
author Luo, Peng
Fang, Jiarui
Chen, Houqing
He, Feng
Xiao, Siying
Liu, He
Zhu, Shizhuang
Luo, Jianzhou
Jiang, Changqing
author_facet Luo, Peng
Fang, Jiarui
Chen, Houqing
He, Feng
Xiao, Siying
Liu, He
Zhu, Shizhuang
Luo, Jianzhou
Jiang, Changqing
author_sort Luo, Peng
collection PubMed
description The crosstalk between osteosarcoma (OS) development and abnormally expressed microRNA (miR)-601 is not explored explicitly. Here, we identified the downregulated miR-601 in osteosarcoma (OS) through a comprehensive bioinformatics analysis of GEO Datasets. The results indicated that miR-601 was downregulated in both OS cells and tissues. The OS patients with reduced expression of miR-601 displayed worse prognosis. The results of in vitro and in vivo assay revealed that elevated miR-601 inhibited the proliferative, migratory and invasive capacities in OS cells. Mechanically, miR-601 exerted its function via targeting oncogene protein kinase membrane associated tyrosine/threonine 1 (PKMYT1) at post-transcriptional level. Moreover, miR-601 was attenuated by c-Myb at transcriptional level. Taken together, our studies reveal that miR-601 is a suppressive gene negatively correlated with malignancy of OS.
format Online
Article
Text
id pubmed-9035158
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90351582022-04-27 c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1 Luo, Peng Fang, Jiarui Chen, Houqing He, Feng Xiao, Siying Liu, He Zhu, Shizhuang Luo, Jianzhou Jiang, Changqing Sci Rep Article The crosstalk between osteosarcoma (OS) development and abnormally expressed microRNA (miR)-601 is not explored explicitly. Here, we identified the downregulated miR-601 in osteosarcoma (OS) through a comprehensive bioinformatics analysis of GEO Datasets. The results indicated that miR-601 was downregulated in both OS cells and tissues. The OS patients with reduced expression of miR-601 displayed worse prognosis. The results of in vitro and in vivo assay revealed that elevated miR-601 inhibited the proliferative, migratory and invasive capacities in OS cells. Mechanically, miR-601 exerted its function via targeting oncogene protein kinase membrane associated tyrosine/threonine 1 (PKMYT1) at post-transcriptional level. Moreover, miR-601 was attenuated by c-Myb at transcriptional level. Taken together, our studies reveal that miR-601 is a suppressive gene negatively correlated with malignancy of OS. Nature Publishing Group UK 2022-04-23 /pmc/articles/PMC9035158/ /pubmed/35461324 http://dx.doi.org/10.1038/s41598-022-10684-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Luo, Peng
Fang, Jiarui
Chen, Houqing
He, Feng
Xiao, Siying
Liu, He
Zhu, Shizhuang
Luo, Jianzhou
Jiang, Changqing
c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title_full c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title_fullStr c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title_full_unstemmed c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title_short c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
title_sort c-myb-mediated inhibition of mir-601 in facilitating malignance of osteosarcoma via augmentation of pkmyt1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035158/
https://www.ncbi.nlm.nih.gov/pubmed/35461324
http://dx.doi.org/10.1038/s41598-022-10684-0
work_keys_str_mv AT luopeng cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT fangjiarui cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT chenhouqing cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT hefeng cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT xiaosiying cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT liuhe cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT zhushizhuang cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT luojianzhou cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1
AT jiangchangqing cmybmediatedinhibitionofmir601infacilitatingmalignanceofosteosarcomaviaaugmentationofpkmyt1